multiple myeloma Archives - Elixi International

30 March 2022

Carvykti (ciltacabtagene autoleucel), new gene therapy to treat adult patients with multiple myeloma

3 April 2021

Abecma (idecabtagene vicleucel), First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma

24 July 2020

Blenrep (belantamab mafodotin), new option for the treatment of relapsed and refractory multiple myeloma

3 March 2020

Sarclisa (isatuximab-irfc), new Therapy for Patients with Previously Treated Multiple Myeloma

10 July 2019

FDA approves Xpovio (selinexor), new treatment for refractory multiple myeloma